Are ADRX insiders buying or selling?

In the last 90 days, ADARx (ADRX) had 0 insider transactions. Track every executive trade, dollar amount, and date.

Which hedge funds own ADRX?

See every hedge fund and asset manager holding ADARx (ADRX).

How much of ADRX trades in dark pools?

Track ADARx (ADRX) dark pool activity and off-exchange block trades.

ADARx (ADRX) Smart Money — Insiders, Congress, Hedge Funds

$18.21

+0.40 (+2.25%)

Weekly Expected Move ±6.8%

$15 $16 $18 $19 $20

NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 35 · $1.9B mcap · 18M float · 4.40% daily turnover · Short 57% of daily vol

Credit Risk of going bust: not rated Bonds: none of note held by US funds details ▾

Not rated: no recent balance sheet.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Smart Money Score

Watch 0

Insider—

Congress—

ETF Holdings—

Key Statistics

Market Cap$1.9B

52W Range16.61-23.21

Volume99,578

Avg Volume795,018

Beta0.00

Dividend—

Analyst Ratings

No analyst coverage

Company Info

CEOZhen Li

Employees100

SectorHealthcare

IndustryBiotechnology

IPO Date2026-09-25

Websiteadarx.com

5871 Oberlin Drive, Suite 200
San Diego, CA 92121
US

About ADARx Pharmaceuticals, Inc.

ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.

Latest News